EYESW (Second Sight Medical Products) Total Liabilities: $2.59 Mil (As of Jun. 2022)


What is Second Sight Medical Products Total Liabilities?

Second Sight Medical Products EYESW Total Liabilities is $2.59 Mil as of Jun. 2022. The stock has 1 warning sign investors should review.

Second Sight Medical Products's Total Liabilities for the quarter that ended in Jun. 2022 was $2.59 Mil.

Second Sight Medical Products's quarterly Total Liabilities declined from Dec. 2021 ($2.51 Mil) to Mar. 2022 ($2.39 Mil) but then increased from Mar. 2022 ($2.39 Mil) to Jun. 2022 ($2.59 Mil).

Second Sight Medical Products's annual Total Liabilities declined from Dec. 2019 ($9.32 Mil) to Dec. 2020 ($5.13 Mil) and declined from Dec. 2020 ($5.13 Mil) to Dec. 2021 ($2.51 Mil).

Second Sight Medical Products Total Liabilities Historical Data

* Premium members only.

The historical data trend for Second Sight Medical Products's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Second Sight Medical Products Total Liabilities Chart

Second Sight Medical Products Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.62 7.60 9.32 5.13 2.51

Second Sight Medical Products Quarterly Data
Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.81 4.02 2.51 2.39 2.59

Second Sight Medical Products Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Second Sight Medical Products's Total Liabilities for the fiscal year that ended in Dec. 2021 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=2.462+(0.052+-3.9551695252271E-16
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=2.51

Total Liabilities=Total Assets (A: Dec. 2021 )-Total Equity (A: Dec. 2021 )
=70.879-68.365
=2.51

Second Sight Medical Products's Total Liabilities for the quarter that ended in Jun. 2022 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=2.591+(0+0
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=2.59

Total Liabilities=Total Assets (Q: Jun. 2022 )-Total Equity (Q: Jun. 2022 )
=65.649-63.058
=2.59

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of $2.59 Mil mean?
Second Sight Medical Products (EYESW) has a Total Liabilities of $2.59 Mil as of Jun. 2022. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Second Sight Medical Products and its competitors.
Is Second Sight Medical Products' Total Liabilities too high?
Second Sight Medical Products' current Total Liabilities is $2.59 Mil.
How does Second Sight Medical Products' Total Liabilities compare to SONX and LUCD?
Second Sight Medical Products' Total Liabilities of $2.59 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Medical Devices & Instruments company?
A good Total Liabilities depends on the Medical Devices & Instruments industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Second Sight Medical Products and its competitors. Second Sight Medical Products's current Total Liabilities is $2.59 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Second Sight Medical Products stock overvalued right now?
Second Sight Medical Products (EYESW) has a current Total Liabilities of $2.59 Mil. The current Total Liabilities is $2.59 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Second Sight Medical Products (EYESW), the current Total Liabilities is $2.59 Mil as of Jun. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Second Sight Medical Products Business Description

Address 13170 Telfair Avenue, Sylmar, CA, USA, 91342
Second Sight Medical Products Inc develops, manufactures, and markets implantable prosthetic devices to create an artificial form of useful vision for blind individuals. The company's product Argus II System treats outer retinal degenerations, such as Retinitis Pigmentosa, often referred to as RP. The company generates revenue from the sale of its Argus II retinal prosthesis systems, which include the implant and external components. Geographically, the company operates in the United States, Italy, China, and of which key revenue is derived from the United States.